Viapath - A New Brand, Same Commitment to Transform Pathology Services
News May 08, 2014
On 1 May, 2014, GSTS Pathology and KingsPath unite to become Viapath, a new brand for one of the UK’s leading specialist providers of pathology services. As a public-private partnership, Viapath remains majority owned by the NHS.
With the commercial freedom to invest in growth and innovation, the company is ambitious and committed to the achievement of high clinical standards and high levels of operating efficiency in pathology services across the UK.
Viapath replaces the current brands - GSTS Pathology and KingsPath - at a time when pathology provision in the UK is in a state of great change.
Richard Jones, CEO, Viapath, said: ‘I am proud to lead a team of exceptional people - top scientists, clinicians, laboratory staff and business specialists. We have a clear vision of how our scientific and clinical knowledge translates into a market-leading portfolio of diagnostic tests and services - and a commitment to work in close partnership with hospital and community healthcare providers to improve the lives of patients, every day.’
The origins of the new Viapath organization were set five years ago, when Guy’s and St Thomas’ NHS Foundation Trust formed GSTS Pathology. This was extended late in 2009, when a partnership to provide pathology services to Bedford Hospital NHS Trust was created. In 2010, King’s College Hospital NHS Foundation Trust became an equal partner.
Now, with around 1,000 employees currently processing more than 22 million tests per annum, the work of Viapath touches thousands of lives every day.
The company’s portfolio includes: specialist assays, innovative new approaches to diagnostic pathways, reference services for specific disease states and full facility management.
Nano-tech Diagnostic Can Indicate Cancer or Thrombotic Risk in One Drop of BloodNews
A team of international researchers led by Professor Martin Hegner, Investigator in CRANN and Trinity’s School of Physics, have developed an automated diagnostic platform that can quantify bleeding – and thrombotic risks – in a single drop of blood, within seconds.READ MORE
Look Before You Flush: Cancer Campaign Encourages VigilanceNews
Be Clear on Cancer campaign urges public to check urine for blood and to inform the doctor ASAPREAD MORE
Diagnosis and Treatment of Heart and Circulatory Diseases a Top Priority for the UKNews
NHS commits to a new focus around heart and circulatory diseases in 10 year planREAD MORE
3rd International Conference on Diagnostic Microbiology and Infectious Diseases
Sep 24 - Sep 25, 2018
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019